Non-competitive AMPA antagonist receptor (IC50 = 2.5 μM). In vivo, displays broad spectrum anticonvulsive activity and neuroprotective effects.
Abraham et al (2000) New non competitive AMPA antagonists. Bioorg.Med.Chem. 8 2127. Solyom (2001) Research on new AMPA antagonists of 2,3-benzodiazepine type. Pharmazie 25 Suppl.1 S62. Bibbiani et al (2005) Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Exp.Neurol. 196 422.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.